Sandy Diaz

Sandy Diaz, Pharm.D., has extensive experience in clinical quality management and assurance, currently serving as the Executive Director and Head of Clinical Quality Management for Oncology and Neurology at Eisai US since May 2019. Previously, Sandy held the position of Sr. Director and Head of Clinical Quality Assurance at AMAG Pharmaceuticals from January 2018 to May 2019. Prior to that, Sandy worked at Eli Lilly and Company from 2012 to 2018, focusing on global quality auditing and compliance as well as clinical quality assurance. Sandy's career also includes significant roles at Pfizer between 2000 and 2011, where responsibilities encompassed clinical QA management and regulatory oversight. Sandy obtained a Doctor of Pharmacy degree from Shenandoah University.